Bicyclic anilide spirohydantoin CGRP receptor antagonists

Details for Australian Patent Application No. 2004222383 (hide)

Owner Merck & Co. Inc.

Inventors Theberge, Cory R.; Stump, Craig; Bell, Ian M.; Zartman, C. Blair; Zhang, XuFang; Gallicchio, Steven N.

Agent Spruson & Ferguson

Pub. Number AU-B-2004222383

PCT Pub. Number WO2004/082605

Priority 60/455,609 14.03.03 US; 60/486,642 11.07.03 US

Filing date 10 March 2004

Wipo publication date 30 September 2004

Acceptance publication date 1 October 2009

International Classifications

C07D 233/02 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Event Publications

1 September 2005 PCT application entered the National Phase

  PCT publication WO2004/082605 Priority application(s): WO2004/082605

1 October 2009 Application Accepted

  Published as AU-B-2004222383

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

4 February 2010 Standard Patent Sealed

4 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004222384-Mitral valve repair system

2004222381-Modified heat-generating cosmetic compositions